Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Graves' ophthalmopathy.

Bahn RS.

N Engl J Med. 2010 Feb 25;362(8):726-38. doi: 10.1056/NEJMra0905750. Review. No abstract available.

2.

Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.

Träisk F, Tallstedt L, Abraham-Nordling M, Andersson T, Berg G, Calissendorff J, Hallengren B, Hedner P, Lantz M, Nyström E, Ponjavic V, Taube A, Törring O, Wallin G, Asman P, Lundell G; Thyroid Study Group of TT 96.

J Clin Endocrinol Metab. 2009 Oct;94(10):3700-7. doi: 10.1210/jc.2009-0747. Epub 2009 Sep 1.

PMID:
19723755
3.

Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment.

Pedro AB, Romaldini JH, Takei K.

Neuroimmunomodulation. 2011;18(1):45-51. doi: 10.1159/000311519. Epub 2010 Jul 13.

PMID:
20628263
4.

Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.

Laurberg P, Berman DC, Andersen S, Bülow Pedersen I.

Thyroid. 2011 Sep;21(9):951-6. doi: 10.1089/thy.2011.0039. Epub 2011 Aug 11.

PMID:
21834677
5.
6.

The tale of radioiodine and Graves' orbitopathy.

Ponto KA, Zang S, Kahaly GJ.

Thyroid. 2010 Jul;20(7):785-93. doi: 10.1089/thy.2010.1640. Review.

PMID:
20578895
7.

Radioiodine therapy versus antithyroid medications for Graves' disease.

Ma C, Xie J, Wang H, Li J, Chen S.

Cochrane Database Syst Rev. 2016 Feb 18;2:CD010094. doi: 10.1002/14651858.CD010094.pub2. Review.

PMID:
26891370
8.

Euthyroid Graves' ophthalmopathy with negative autoantibodies.

Cakir M.

J Natl Med Assoc. 2005 Nov;97(11):1547-9.

9.

Rapid progression of Graves' ophthalmopathy despite the administration of thiamazole.

Katsuyama T, Takeda M, Otsuka F, Toma K, Inagaki K, Sada KE, Mimura Y, Ogura T, Makino H.

Intern Med. 2013;52(20):2317-20.

10.
11.

[Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement].

Bednarczuk T, Bar-Andziak E, Hubalewska-Dydejczyk A, Waligórska A, Górska M, Myśliwiec J, Jarzab B, Karczmarzyk R, Zawadzka A, Garmol D, Kecik D, Królicki L, Plazińska MT, Krzeski A, Krzyzanowska-Swiniarska B, Lewiński A, Milewicz A, Daroszewski J, Placzkiewicz-Jankowska E, Pilarska K, Skórski M, Wiechno W, Sowiński J, Syrenicz A, Szafilk J, Wanyura H, Zgliczński W, Jastrzebska H, Nauman J.

Endokrynol Pol. 2009 Jul-Aug;60(4):312-30. Review. Polish. No abstract available.

PMID:
19753546
12.

Management of Graves' ophthalmopathy.

Wiersinga WM.

Nat Clin Pract Endocrinol Metab. 2007 May;3(5):396-404. Review.

PMID:
17452966
13.

Risk Factors for Graves' Orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study.

Khong JJ, Finch S, De Silva C, Rylander S, Craig JE, Selva D, Ebeling PR.

J Clin Endocrinol Metab. 2016 Jul;101(7):2711-20. doi: 10.1210/jc.2015-4294. Epub 2016 Apr 7.

PMID:
27055083
14.

Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.

Acharya SH, Avenell A, Philip S, Burr J, Bevan JS, Abraham P.

Clin Endocrinol (Oxf). 2008 Dec;69(6):943-50. doi: 10.1111/j.1365-2265.2008.03279.x. Epub 2008 Apr 21. Review.

PMID:
18429949
15.

Thyroid-associated ophthalmopathy in juvenile Graves' disease--clinical, endocrine and therapeutic aspects.

Krassas GE, Gogakos A.

J Pediatr Endocrinol Metab. 2006 Oct;19(10):1193-206. Review.

PMID:
17172081
16.

[Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].

Chen DY, Chen TH.

Zhonghua Er Ke Za Zhi. 2005 Jul;43(7):507-9. Chinese.

PMID:
16083551
17.

Childhood Graves' ophthalmopathy: results of a European questionnaire study.

Krassas GE, Segni M, Wiersinga WM.

Eur J Endocrinol. 2005 Oct;153(4):515-21.

18.

Post-radioiodine De Novo Onset Graves' Ophthalmopathy: Case Reports and a Review of the Literature.

Batra R, Krishnasamy SK, Buch H, Sandramouli S.

Semin Ophthalmol. 2015 May;30(3):227-31. doi: 10.3109/08820538.2013.839801. Epub 2014 Jan 10. Review.

PMID:
24409943
19.

Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.

Gunji K, De Bellis A, Li AW, Yamada M, Kubota S, Ackrell B, Wengrowicz S, Bellastella A, Bizzarro A, Sinisi A, Wall JR.

J Clin Endocrinol Metab. 2000 Apr;85(4):1641-7.

PMID:
10770210
20.

[A special case of thyroid associated ophthalmopathy in the course of Graves-Basedow disease].

Bałdys-Waligórska A, Kuśnierz-Cabala B, Huszno B.

Endokrynol Pol. 2006 Sep-Oct;57(5):536-40. Polish.

PMID:
17133319

Supplemental Content

Support Center